About ResMed
ResMed is a pioneering medical technology company that develops cloud-connected medical devices and software solutions for people with sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic respiratory conditions. Founded in 1989, the company has grown into a global leader in sleep and respiratory care, serving millions of patients across more than 140 countries. ResMed's comprehensive portfolio includes continuous positive airway pressure (CPAP) devices, ventilators, masks, and digital health platforms that enable remote patient monitoring and care management. The company's technology approach combines advanced hardware engineering with cloud-based software and data analytics to deliver personalized therapy and improve patient outcomes. ResMed serves a diverse customer base including hospitals, sleep clinics, home medical equipment providers, and individual patients. Their solutions integrate with healthcare systems to provide clinicians with actionable insights and enable value-based care models. The company is committed to transforming care delivery through innovation in connected health, helping patients breathe easier, sleep better, and live healthier lives while reducing healthcare costs.
Clinical Focus
Medical conditions and clinical areas addressed by ResMed.
Who It Serves
Company Details
- Founded
- 1989
- Headquarters
- San Diego, CA, USA
- Employees
- 5001-10000
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 46 →
Abbott Diabetes Care
Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.
Amalgam Rx
Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.
Arkray
ARKRAY USA manufactures and distributes blood glucose monitoring systems, clinical diagnostic equipment, and oral wellness products. The company serves consumers with diabetes, healthcare professionals, and clinical laboratories with accurate, affordable diagnostic solutions.
BeatO
BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.
Brook Health
AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.
Cadence
Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.
Cala Health
Cala Health develops the Cala kIQ System, an FDA-cleared wearable device that delivers non-invasive neuromodulation therapy for action hand tremor. The device uses transcutaneous afferent patterned stimulation (TAPS) to provide on-demand tremor relief for people with essential tremor and Parkinson's disease.
Calibrate
Calibrate is a metabolic health company that combines clinician-prescribed GLP-1 medications with 1:1 video coaching and science-backed curriculum to help members achieve sustainable weight loss. Members lose an average of 19% of their body weight achieved over three years.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.